Jeff Yass’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,600
| Closed | -$450K | – | 13080 |
|
|
2024
Q1 | $450K | Buy |
12,600
+5,500
| +77% | +$190K | ﹤0.01% | 8752 |
|
|
2023
Q4 | $234K | Sell |
7,100
-4,100
| -37% | -$110K | ﹤0.01% | 10355 |
|
|
2023
Q3 | $305K | Sell |
11,200
-8,200
| -42% | -$247K | ﹤0.01% | 9309 |
|
|
2023
Q2 | $612K | Buy |
+19,400
| New | +$603K | ﹤0.01% | 7843 |
|
|
2023
Q1 | – | Sell |
-8,300
| Closed | -$252K | – | 13378 |
|
|
2022
Q4 | $252K | Sell |
8,300
-1,000
| -11% | -$30.1K | ﹤0.01% | 9526 |
|
|
2022
Q3 | $280K | Sell |
9,300
-8,700
| -48% | -$275K | ﹤0.01% | 9966 |
|
|
2022
Q2 | $498K | Sell |
18,000
-9,500
| -35% | -$271K | ﹤0.01% | 8270 |
|
|
2022
Q1 | $925K | Sell |
27,500
-600
| -2% | -$20.8K | ﹤0.01% | 7326 |
|
|
2021
Q4 | $1.19M | Buy |
28,100
+5,700
| +25% | +$254K | ﹤0.01% | 6839 |
|
|
2021
Q3 | $1.02M | Sell |
22,400
-200
| -0.9% | -$9.18K | ﹤0.01% | 7517 |
|
|
2021
Q2 | $1.11M | Sell |
22,600
-14,500
| -39% | -$695K | ﹤0.01% | 7490 |
|
|
2021
Q1 | $1.86M | Buy |
37,100
+7,700
| +26% | +$426K | ﹤0.01% | 6090 |
|
|
2020
Q4 | $1.51M | Buy |
29,400
+8,900
| +43% | +$423K | ﹤0.01% | 5733 |
|
|
2020
Q3 | $843K | Buy |
20,500
+7,500
| +58% | +$309K | ﹤0.01% | 6533 |
|
|
2020
Q2 | $544K | Buy |
13,000
+4,200
| +48% | +$166K | ﹤0.01% | 7192 |
|
|
2020
Q1 | $279K | Sell |
8,800
-72,000
| -89% | -$2.75M | ﹤0.01% | 8115 |
|
|
2019
Q4 | $3.42M | Buy |
80,800
+16,600
| +26% | +$616K | ﹤0.01% | 3500 |
|
|
2019
Q3 | $2.03M | Buy |
64,200
+6,500
| +11% | +$228K | ﹤0.01% | 4158 |
|
|
2019
Q2 | $2.08M | Buy |
57,700
+12,100
| +27% | +$417K | ﹤0.01% | 4091 |
|
|
2019
Q1 | $1.65M | Buy |
45,600
+27,100
| +146% | +$905K | ﹤0.01% | 4064 |
|
|
2018
Q4 | $521K | Buy |
18,500
+10,800
| +140% | +$358K | ﹤0.01% | 5966 |
|
|
2018
Q3 | $303K | Sell |
7,700
-10,300
| -57% | -$391K | ﹤0.01% | 7470 |
|
|
2018
Q2 | $671K | Sell |
18,000
-13,400
| -43% | -$486K | ﹤0.01% | 6212 |
|
|
2018
Q1 | $1.07M | Buy |
31,400
+13,200
| +73% | +$463K | ﹤0.01% | 5077 |
|
|
2017
Q4 | $597K | Buy |
18,200
+2,800
| +18% | +$87.6K | ﹤0.01% | 6298 |
|
|
2017
Q3 | $480K | Buy |
15,400
+1,800
| +13% | +$52.8K | ﹤0.01% | 6576 |
|
|
2017
Q2 | $379K | Sell |
13,600
-1,200
| -8% | -$31.2K | ﹤0.01% | 7152 |
|
|
2017
Q1 | $381K | Buy |
14,800
+1,000
| +7% | +$24.9K | ﹤0.01% | 6977 |
|
|
2016
Q4 | $316K | Sell |
13,800
-3,900
| -22% | -$93.4K | ﹤0.01% | 7875 |
|
|
2016
Q3 | $462K | Sell |
17,700
-9,700
| -35% | -$242K | ﹤0.01% | 6199 |
|
|
2016
Q2 | $620K | Buy |
+27,400
| New | +$651K | ﹤0.01% | 5765 |
|
Other funds holding SBIO
CIS
MWM
GAM
Jeff Yass's SBIO Position: Q2 2026 in Review
Jeff Yass sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2026, closing a stake of 60,686 shares — an estimated $3.18M sold.
Jeff Yass first reported a position in SBIO in Q2 2015 and held it in 33 quarters. The position peaked at $3.18M in Q1 2026. 64 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.
- Jeff Yass reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2026 after selling out during the quarter.
- Jeff Yass sold 60,686 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $3.18M.
- Jeff Yass first reported a position in ALPS Medical Breakthroughs ETF in Q2 2015 and held it in 33 quarters.
- Jeff Yass's ALPS Medical Breakthroughs ETF position peaked at $3.18M in Q1 2026.
- 64 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.